Clinical research of operation in the treatment for potentially resectable cancer of pancreatic body-tail / 天津医药

ABSTRACT

@#Objective Todiscusstheclinicaleffectandtechnicalmethodofthesurgicaltreatmentforpotentially resectablecancerofpancreaticbody-tail.Methods Elevenpatientswithpotentiallyresectablecancerofpancreaticbodytailoradjacentorganmetastasis,whounderwentwideexcisionandpostoperativechemotherapyinourdepartmentwere retrospectivelyanalyzed. Results Inelevenpatients,10patientswithadjacentorganmetastasiswereperformedinvolved organsresection,3patientsweregivenresectionoftheceliacaxis(CA)andcommonhepaticartery(CHA)and2patients weregiventotalgastrectomyandjejunalinterpositionpouchreconstruction.Onepatienthadprolongedhospitalstaydueto incisioninfection,butnoseriouscomplicationsoccurredinotherpatients.Exceptfor2patients,theotherpatientsunderwent postoperativechemotherapyofgemcitabine.Allofthepatientsachievedreliefthroughoperation.Themediansurvivaltime was 28 (14, 36) months. One and 3-year survival rates were 90.9% and 36.3%. Conclusion The resection rate of potentiallyresectablecarcinomaofpancreaticbodyandtailoperationislower,andpatientshavelongbeenplaguedby abdominal pain. The treatment of extensive resection operation and recessive resection and postoperative adjuvant chemotherapycanimprovethequalityoflifeandprolongthesurvivalrateofpatients.